eISSN: 2299-0054
ISSN: 1895-4588
Videosurgery and Other Miniinvasive Techniques
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2024
vol. 19
 
Share:
Send email
Share:
abstract:
Original paper

Outcomes of minimally invasive surgery for pulmonary metastasis: who benefits the most?

Burcu Kılıç
1
,
Ömer Faruk Sağlam
1
,
Levani Chikvaidzade
1
,
Ezel Erşen
1
,
Hasan Volkan Kara
1
,
Akif Turna
1
,
Kamil Kaynak
1
,
Ahmet Demirkaya
2

  1. Department of Thoracic Surgery, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey
  2. Department of Thoracic Surgery, Faculty of Medicine, Istanbul Beykent University, Istanbul, Turkey
Videosurgery Miniinv 2024; 19 (2): 254–265
DOI: https://doi.org/10.5114/wiitm.2024.140300
Online publish date: 2024/06/17
View full text Get citation
 
PlumX metrics:
Introduction
Metastatic disease is one of the main causes of death and factors affecting overall survival. It is known that selected patients with pulmonary oligometastases whose primary tumor is under control and who have adequate respiratory capacity may benefit from metastasectomy by resecting all detected lesions.

Aim
To report our findings on the use of video-assisted thoracoscopic surgery (VATS) for pulmonary metastasectomy, with a focus on identifying suitable candidates.

Material and methods
Between August 2010 and 2023 a total of 532 pulmonary metastasectomy procedures were performed in our institution. Metastasectomy was performed with VATS for 281 of those patients.

Results
VATS metastasectomy was performed in 131 patients with a single lesion on preoperative imaging, while 110 patients underwent metastasectomy for multiple lesions. The rate was significantly (p < 0.05) lower in the group with multiple lesions removed during surgery (38 months) than in the group with only one lesion removed during surgery (60 months). The predicted survival time in the group with other tumor histology (79 months) was significantly (p < 0.05) higher than in the groups with tumor histology carcinoma (41.4 months) and sarcoma (55.5 months).

Conclusions
The best prognosis after metastasectomy is provided in cases with a single nodule. Grade is also an important prognostic factor affecting survival, particularly for grade 1 tumor. The histopathological type of the primary tumor is also a significant prognostic factor affecting survival after pulmonary metastasectomy in secondary pulmonary neoplasms, particularly for sarcoma and carcinoma.

keywords:

minimally invasive thoracic surgery, pulmonary metastasectomy, video-assisted thoracic surgery
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.